Bioventus Inc. (BVS)
undefined
undefined%
At close: undefined
9.60
-2.34%
After-hours Jan 06, 2025, 07:20 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY15 FY14 FY13
Net Income -121.20M -213.39M 9.59M 14.72M 8.11M 4.44M -34.11M -12.90M -22.37M
Depreciation & Amortization 57.37M 66.80M 34.88M 28.64M 30.32M 29.24M 33.08M 28.82M 24.46M
Stock-Based Compensation 2.72M 17.59M 19.84M 10.10M 10.84M 14.32M 3.33M 2.35M 576.00K
Other Working Capital -13.24M 22.10M -14.62M -733.00K -3.88M -422.00K 1.17M -25.48M 1.33M
Other Non-Cash Items 82.01M 182.79M 6.08M 3.53M 5.36M -5.59M 20.35M 6.35M 11.86M
Deferred Income Tax -2.38M -52.79M -9.76M -511.00K -348.00K -79.00K -432.00K -701.00K -475.00K
Change in Working Capital -3.18M -14.53M -13.28M 15.31M -13.57M 2.85M -10.65M -12.01M -16.41M
Operating Cash Flow 15.34M -13.54M 22.99M 71.80M 40.71M 45.19M 18.92M 15.11M 2.75M
Capital Expenditures -7.36M -11.52M -7.37M -20.67M -8.34M -6.06M -7.44M -20.83M -6.36M
Acquisitions 34.67M -104.84M -262.87M n/a 430.00K n/a -51.46M -10.55M n/a
Purchase of Investments n/a n/a -13.52M n/a n/a n/a -941.00K n/a n/a
Sales Maturities Of Investments n/a n/a 276.39M n/a 430.00K n/a n/a n/a n/a
Other Investing Acitivies -11.51M -75.00K -276.39M 172.00K 430.00K -40.00K -1.28M -19.67M -4.64M
Investing Cash Flow 15.81M -116.44M -283.76M -20.50M -7.91M -6.10M -60.19M -31.38M -11.00M
Debt Repayment -23.26M 59.62M 166.20M -10.00M -1.37M -5.25M -17.74M -4.25M 9.30M
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a -367.00K -19.89M -9.14M -7.85M -1.02M -2.40M -2.50M
Other Financial Acitivies -4.17M -3.37M -1.88M 317.00K -448.00K -160.00K 50.00M n/a n/a
Financial Cash Flow -26.65M 62.08M 273.37M -29.57M -10.95M -13.26M 31.25M -6.64M 6.80M
Net Cash Flow 5.13M -67.38M 12.37M 22.32M 21.75M 25.67M -10.82M -24.34M -1.96M
Free Cash Flow 7.98M -25.06M 15.62M 51.13M 32.37M 39.13M 11.48M -5.72M -3.61M